Virtual Care for Heart Failure - Randomized Clinical Trial (RCT) (Pilot Phase)

Sponsor
Population Health Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05724433
Collaborator
Hamilton Health Sciences Corporation (Other), McMaster University (Other)
50
3
2
11.7
16.7
1.4

Study Details

Study Description

Brief Summary

Heart failure (HF) is a leading cause of death, hospitalization, and healthcare system expenditure in Canada. While care in HF clinics - multidisciplinary clinics that focus on optimal management of HF - improves health outcomes in HF, there are disparities in access to such care across our province. To respond to the needs of patients and the health care system, the investigators propose to develop and implement a virtual model of care that will enable Canadians with HF to receive outpatient HF care and medical optimization remotely. The investigators will assess the feasibility of this model of care in a pilot randomized controlled trial, and collect feedback from patients and providers. The investigators hypothesize that virtual clinics will be feasible. The investigators will also measure healthcare processes, and use these to guide a larger clinical trial that will measure clinical outcomes in patients receiving virtual versus usual care.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual HF Care
  • Other: Routine HF Care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization (VICTORY-HF) RCT (Pilot Phase)
Actual Study Start Date :
Dec 9, 2022
Anticipated Primary Completion Date :
Jun 9, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual HF care

Patients will receive virtual HF care to optimize medical therapies

Other: Virtual HF Care
Patients will receive virtual visits for 3 months following hospitalization / emergency department (ED) visit for HF. Physiologic measures will be monitored remotely and therapies will be optimized.

Other: Routine HF care

Participants will receive routine HF care

Other: Routine HF Care
Care as determined by the treating physician

Outcome Measures

Primary Outcome Measures

  1. Change in heath status [90 days]

Secondary Outcome Measures

  1. Number of patients randomized [90 days]

  2. Proportion of patients allocated to the virtual HF clinic who require crossover to the routine HF clinic [90 days]

  3. Proportion of patients that are seen in clinic within 7 days post discharge [date of discharge to 7 days]

  4. Proportion of patients on all classes of guideline-directed medical therapy (GDMT) at baseline, 30 days and 90 days [90 days]

  5. Proportion of patients who have heath status data collected at baseline, 30 days and 90 days [90 days]

  6. Qualitative feedback on patient satisfaction and usability of technology [90 days]

  7. Number of visits per patient during 90 days [90 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Adult patients ≥ 18 years old who:
  1. are being discharged after hospitalization or urgent visit (emergency department) for HF OR have been referred for an initial consult at a cardiology clinic within 30 days of hospitalization or urgent visit for HF

  2. have left ventricular ejection fraction (LVEF) < 55% within the preceding 3 months

  3. Have NT-proBNP of > 900 pg/ml

  4. have a mailing address for the patient or caregiver

  5. are competent (either independently or with caregiver) in using the virtual care platform during a brief demonstration

  6. provide consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Joseph's Healthcare Hamilton Hamilton Onatrio Canada L8N 4A6
2 Hamilton General Hospital Hamilton Ontario Canada L8L 2X2
3 Juravinski Hospital Cancer Centre Hamilton Ontario Canada L8V 5C2

Sponsors and Collaborators

  • Population Health Research Institute
  • Hamilton Health Sciences Corporation
  • McMaster University

Investigators

  • Principal Investigator: Harriette Van Spall, MD, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Harriette Van Spall, Assistant Professor of Medicine, Division of Cardiology, McMaster University, Population Health Research Institute, Population Health Research Institute
ClinicalTrials.gov Identifier:
NCT05724433
Other Study ID Numbers:
  • VICTORY-HF RCT (Pilot Phase)
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Harriette Van Spall, Assistant Professor of Medicine, Division of Cardiology, McMaster University, Population Health Research Institute, Population Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023